Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9405225rdf:typepubmed:Citationlld:pubmed
pubmed-article:9405225lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9405225lifeskim:mentionsumls-concept:C0227651lld:lifeskim
pubmed-article:9405225lifeskim:mentionsumls-concept:C0387583lld:lifeskim
pubmed-article:9405225lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:9405225lifeskim:mentionsumls-concept:C0048897lld:lifeskim
pubmed-article:9405225lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:9405225lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:9405225pubmed:issue1lld:pubmed
pubmed-article:9405225pubmed:dateCreated1998-1-15lld:pubmed
pubmed-article:9405225pubmed:abstractTextTetrahydrobiopterin (BH4) biosynthetic pathways are stimulated under inflammatory conditions. The newly synthesized BH4 serves as a cofactor for optimal activity of inducible nitric oxide synthase (NOS2). In human mesangial cells (HMC), BH4 is also a limiting factor for NOS2 expression. In this study we show that BH4 availability can also play a modulatory role in the expression of cyclooxygenase 2 (COX-2) in HMC. Supplementing HMC with the BH4 donor sepiapterin potentiated IL-1beta/TNF-alpha-induced COX-2 expression by approximately 2-fold. This effect was abolished by methotrexate. In contrast, the NOS inhibitor L-NAME and the soluble guanylate cyclase inhibitor ODQ did not block sepiapterin amplification of COX-2 expression. Moreover, sepiapterin was found to modulate the tyrosine phosphorylation of several cellular substrates, an early event which occurred well before the induction of NOS2 could be evidenced. These findings suggest a role for BH4 in the modulation of mesangial cell responses to pro-inflammatory stimuli.lld:pubmed
pubmed-article:9405225pubmed:languageenglld:pubmed
pubmed-article:9405225pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:citationSubsetIMlld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9405225pubmed:statusMEDLINElld:pubmed
pubmed-article:9405225pubmed:monthDeclld:pubmed
pubmed-article:9405225pubmed:issn0006-291Xlld:pubmed
pubmed-article:9405225pubmed:authorpubmed-author:RonMMlld:pubmed
pubmed-article:9405225pubmed:authorpubmed-author:LamasSSlld:pubmed
pubmed-article:9405225pubmed:authorpubmed-author:JiménezWWlld:pubmed
pubmed-article:9405225pubmed:authorpubmed-author:Pérez-SalaDDlld:pubmed
pubmed-article:9405225pubmed:authorpubmed-author:Díaz-CazorlaM...lld:pubmed
pubmed-article:9405225pubmed:copyrightInfoCopyright 1997 Academic Press.lld:pubmed
pubmed-article:9405225pubmed:issnTypePrintlld:pubmed
pubmed-article:9405225pubmed:day8lld:pubmed
pubmed-article:9405225pubmed:volume241lld:pubmed
pubmed-article:9405225pubmed:ownerNLMlld:pubmed
pubmed-article:9405225pubmed:authorsCompleteYlld:pubmed
pubmed-article:9405225pubmed:pagination7-12lld:pubmed
pubmed-article:9405225pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:meshHeadingpubmed-meshheading:9405225-...lld:pubmed
pubmed-article:9405225pubmed:year1997lld:pubmed
pubmed-article:9405225pubmed:articleTitleTetrahydrobiopterin modulates cyclooxygenase-2 expression in human mesangial cells.lld:pubmed
pubmed-article:9405225pubmed:affiliationInstituto "Reina Sofía" de Investigaciones Nefrológicas, C.S.I.C., Velázquez 144, Madrid, 28006, Spain. lperezsala@fresno.csic.eslld:pubmed
pubmed-article:9405225pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9405225pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed